Call from Friday October 9th, 2026 featuring Dr. Shmuel Shoham.

Shmuel Shoham, M.D. is Professor of Medicine at Johns Hopkins University School of Medicine.

Dr. Shoham has over 20 years of experience in management of patients with invasive infections, and is the author or co-author of over 100 original articles, book chapters and topic reviews. He is a nationally recognized expert in infectious diseases of immunocompromised patients and his research explores diagnosis, prevention and treatment of infections in such patients. Dr. Shoham serves as a reviewer and expert consultant to multiple journals, professional societies, hospitals and government agencies in the US and numerous countries abroad.

He is a member of professional guideline committees for the American Society of Transplantation (AST), the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and Infectious Diseases Mycoses Study Group (EORTC/MSG) and the National Comprehensive Cancer Network (NCCN). Dr. Shoham is the recipient of numerous awards including the American College of Physicians' (Washington, DC Chapter) laureate award, their highest honor.

Dr. Shoham received his medical degree from Thomas Jefferson University (Philadelphia, PA) and medical residency and infectious diseases fellowship training at Boston University School of Medicine (Boston, MA).

Call from Friday October 2nd, 2026 featuring Dr. Jon Zenilman.

Dr. Jonathan M. Zenilman is a professor of medicine, at the Johns Hopkins University School of Medicine. He also has joint appointments in population family and reproductive health, international health, and epidemiology at the Johns Hopkins University Bloomberg School of Public Health.

Dr. Zenilman is known internationally for his work in infectious disease epidemiology. Prior to coming to Johns Hopkins in 1989, he was a medical epidemiologist at the U.S. Centers for Disease Control (CDC) where he developed the National Gonococcal Isolate Surveillance Program (GISP). , which has operated continuously since 1987. He also coordinated and wrote the 1989 STD Treatment Guidelines and has continuously consulted with CDC since.

In Baltimore, his activities have included directing the Baltimore City Health Department Sexually Transmitted Infection (STI) program and developing the Johns Hopkins Center for STI Prevention and Training. His research encompassed nearly all areas of STD behavioral science and clinical epidemiology, as well as extensive experience in conducting Phase 1 through Phase 3 clinical trials for drugs and vaccines. In addition to being a productive researcher and clinician, he has been active in health policy, has served as a Senior Medical Advisor for the Office of the Assistant Secretary for Planning and Evaluation (DHHS) 1995-1997, has testified before Congress and the Maryland legislature on infectious diseases related issues. He has been a technical consultant on numerous advisory committees for CDC, NIH, DoD, and the US Presidential Commission on Bioethical Issues and on numerous data safety monitoring committees for drugs and vaccines.

Call from Friday September 25th, 2026 featuring Dr. Su Thavarajah.

Dr. Sumeska Thavarajah is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of expertise include nephrology.

Dr. Thavarajah earned her M.D. at Wayne State University School of Medicine. She completed her residency at the University of Connecticut Health Center and performed nephrology fellowships at Johns Hopkins Bayview Medical Center and the University of Connecticut Health Center.

She serves as chair of the National Kidney Foundation of Maryland's Medical Advisory Board. She was recognized by the National Kidney Foundation of Maryland with a Linda Cameron Award for Patient Services in 2015.